[HTML][HTML] Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

…, I Oriol-Bermúdez, A Artero, J Olalla Sierra… - BMC infectious …, 2021 - Springer
Background Since December 2019, the COVID-19 pandemic has changed the concept of
medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital …

The value of telephone consultations during COVID-19 pandemic. An observational study

…, MD Martín-Escalante, J Olalla-Sierra… - … Journal of Medicine, 2021 - academic.oup.com
Background Many Spanish hospitals converted scheduled in-person visits to telephone
visits during the COVID-19 lockdown. There is scarce information about the performance of …

Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain

J Olalla-Sierra, MD Martín-Escalante, J García-Alegría… - AIDS, 2022 - journals.lww.com
Objective: To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes
between persons with and without HIV. Design: Retrospective observational cohort study in 150 …

[HTML][HTML] Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

…, B Hernández-Novoa, J Olalla-Sierra… - Scientific Reports, 2020 - nature.com
Human immunodeficiency virus (HIV) remains incurable due to latent viral reservoirs
established in non-activated CD4 T cells that cannot be eliminated via antiretroviral therapy. …

Reconstitution inflammatory syndrome like reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a HIV patient

SM Gómez-Espejo, J Olalla-Sierra, P Marí-Jiménez… - Mycopathologia, 2017 - Springer
We describe an unusual clinical association of disseminated histoplasmosis with reactive
hemophagocytic syndrome. We report the case of a new HIV-positive patient with …

Clinical results with a B cell activating Anti-CD73 antibody for the immunotherapy of COVID-19

…, JS Overcash, M Waters, M Cameron, J Olalla Sierra… - MedRxiv, 2021 - medrxiv.org
Robust polyclonal humoral immune responses have the potential to generate a diverse set
of antibodies to neutralize and eliminate viruses such as SARS-CoV-2 and protect against …

[HTML][HTML] Use of tenofovir Alafenamide/Emtricitabine/Elvitegravir-cobicistat in HIV-naive patients with advanced disease: GENIS study

J Perez Stachowski, D Rial Crestelo… - Journal of Clinical …, 2022 - mdpi.com
Objective: The primary endpoint of the study was to determine the proportion of patients with
HIV RNA < 50 copies/mL at 48 weeks. Design: Phase IV, multicentric, open-label, single-…

[PDF][PDF] Colonic leishmaniasis in a patient with HIV: a case report

E Soria-López, J Olalla-Sierra… - Revista Española de …, 2016 - scholar.archive.org
Background: To describe an unusual clinical presentation of visceral leishmaniasis affecting
the colon. Case report: We report the case of an HIV-positive patient with visceral …

Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study

…, I de los Santos-Gil, J Olalla-Sierra… - Enfermedades …, 2015 - europepmc.org
Methods A cross-sectional survey including every HIV infected patient in care in 19 hospitals
across Spain in 2012, with≥ 1 indication to start ART according to 2011 national treatment …

Brief Report: CYP27B1 Rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study

…, LF López-Cortés, J Olalla-Sierra… - JAIDS Journal of …, 2020 - journals.lww.com
Background: HIV/AIDS progression is linked to vitamin D, which is regulated by several key
cytochromes P450 (CYP). Single nucleotide polymorphisms (SNPs) in CYP genes influence …